Close Menu

Quidel

Roche's investment in Foundation of up to $1.2B sent Foundation's stock soaring. Otherwise, firms in the GenomeWeb Index saw a mixed month. 

The company expects revenues in the range of $63 million to $64 million for the fourth quarter and $182 million to $183 million for full-year 2014.

Trends included expanding test menus and a possible tipping point for point-of-care.

The clearance is the fourth for a Quidel test on the AmpliVue handheld MDx format.

The company announced its plans for a public offering of the notes last week to fund working capital and general corporate purposes.

Quidel announced the pricing of its previously announced underwritten public offering of $150 million in convertible senior notes.

Quidel will use the net proceeds from the offering for working capital and other general corporate purposes.

NEW YORK (GenomeWeb) — In an effort to design primers that might solve the conundrum of the plateau effect in PCR amplification, researchers at Ohio State University and Ilia State University in the country of Georgia have created a method called quadruplex priming amplification.

This article has been updated from a previous version to include comments from Quidel's Q3 earnings call.

NEW YORK (GenomeWeb) – Quidel has received US Food and Drug Administration 510(k) clearance for its human parainfluenza virus molecular diagnostic test, the firm said today.

Pages

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.